Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8652 |
High Similarity |
NPD3027 |
Phase 3 |
0.8625 |
High Similarity |
NPD7228 |
Approved |
0.8601 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8601 |
High Similarity |
NPD1613 |
Approved |
0.8535 |
High Similarity |
NPD6234 |
Discontinued |
0.8408 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8408 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8408 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8322 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8312 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8252 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8217 |
Intermediate Similarity |
NPD37 |
Approved |
0.8199 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8182 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8171 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8146 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8133 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8121 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8084 |
Intermediate Similarity |
NPD7240 |
Approved |
0.8072 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7988 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7945 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.787 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7838 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7832 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7832 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7832 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7824 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7811 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7764 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7755 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7719 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7709 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7683 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7661 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7643 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7637 |
Intermediate Similarity |
NPD7680 |
Approved |
0.763 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7622 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7607 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7558 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.75 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7483 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.747 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7431 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7417 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7415 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.74 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7394 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7394 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7394 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7342 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7308 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7305 |
Intermediate Similarity |
NPD228 |
Approved |
0.7283 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7278 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7254 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7246 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7244 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7244 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD3382 |
Approved |
0.7229 |
Intermediate Similarity |
NPD3384 |
Approved |
0.7229 |
Intermediate Similarity |
NPD3383 |
Approved |
0.7215 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7211 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7207 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7207 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7207 |
Intermediate Similarity |
NPD6841 |
Approved |
0.72 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7163 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7163 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7161 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.716 |
Intermediate Similarity |
NPD1511 |
Approved |
0.716 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7133 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7115 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7108 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7107 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7107 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7105 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7089 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7086 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7078 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7073 |
Intermediate Similarity |
NPD1512 |
Approved |
0.707 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7069 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7048 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7044 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7041 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7035 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7022 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7019 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7019 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7017 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7012 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7011 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7011 |
Intermediate Similarity |
NPD27 |
Approved |
0.7 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD7124 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6986 |
Remote Similarity |
NPD6671 |
Approved |
0.6983 |
Remote Similarity |
NPD8313 |
Approved |
0.6983 |
Remote Similarity |
NPD7312 |
Approved |
0.6983 |
Remote Similarity |
NPD7311 |
Approved |
0.6983 |
Remote Similarity |
NPD8312 |
Approved |
0.6983 |
Remote Similarity |
NPD7310 |
Approved |
0.6983 |
Remote Similarity |
NPD7313 |
Approved |
0.6982 |
Remote Similarity |
NPD5772 |
Approved |
0.6982 |
Remote Similarity |
NPD7819 |
Suspended |
0.6982 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD5773 |
Approved |
0.6975 |
Remote Similarity |
NPD7466 |
Approved |
0.6975 |
Remote Similarity |
NPD3892 |
Phase 2 |
0.6975 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6975 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6961 |
Remote Similarity |
NPD4663 |
Approved |
0.6954 |
Remote Similarity |
NPD2969 |
Approved |
0.6954 |
Remote Similarity |
NPD2970 |
Approved |
0.6951 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6951 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6944 |
Remote Similarity |
NPD8053 |
Approved |
0.6944 |
Remote Similarity |
NPD7309 |
Approved |
0.6944 |
Remote Similarity |
NPD8054 |
Approved |
0.6943 |
Remote Similarity |
NPD4140 |
Approved |
0.6937 |
Remote Similarity |
NPD2161 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.6932 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6923 |
Remote Similarity |
NPD7243 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD3060 |
Approved |
0.6908 |
Remote Similarity |
NPD5327 |
Phase 3 |
0.6905 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6897 |
Remote Similarity |
NPD3051 |
Approved |
0.6897 |
Remote Similarity |
NPD6071 |
Discontinued |
0.6897 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6894 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6894 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6894 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.6889 |
Remote Similarity |
NPD4577 |
Approved |
0.6889 |
Remote Similarity |
NPD4578 |
Approved |
0.6887 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6883 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6879 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6867 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD7526 |
Approved |
0.6867 |
Remote Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD5846 |
Approved |
0.6867 |
Remote Similarity |
NPD52 |
Approved |
0.6855 |
Remote Similarity |
NPD6353 |
Approved |
0.6852 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6848 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6842 |
Remote Similarity |
NPD2563 |
Approved |
0.6842 |
Remote Similarity |
NPD5402 |
Approved |
0.6842 |
Remote Similarity |
NPD2560 |
Approved |
0.6835
|
Remote Similarity |
NPD2238 |
Phase 2 |